The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
April 18th 2025
From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.
What We're Reading: VA Healthcare Operations Still Require "Urgent Reform"
July 6th 2016What we're reading, July 6, 2016: the Department of Veterans Affairs has made progress, but still has a long way to go; court upholds 6-month delay for biosimilars; and Apple promotes organ donation with iPhone app.
Read More
Safety Profile of New Pan-Genomic HCV Drug Similar to Current Treatments
July 3rd 2016After reviewing the evidence for all approved hepatitis C virus treatments, Advera Health has determined that Gilead Sciences’ newly approved, pan-genomic Epclusa has a similar safety profile as Sovaldi, Harvoni, Daklinza, and Viekira Pak.
Read More
What We're Reading: DOJ Skeptical About Anthem-Cigna Merger
June 30th 2016What we're reading, June 30, 2016: concerns over Anthem-Cigna deal may mean the government moves to block the merger; why the price of childhood vaccines is actually too low; and saturated fats are not as bad as once thought.
Read More
What We're Reading: A New Approach to Care for Super-Utilizers
June 30th 2016What we're reading, July 4, 2016: a hospital is offering free housing to get super-utilizers out of the emergency room; campaigns for patients to gain access to stem cell treatments are gaining momentum; and why hospital/physician integration and consolidation probably won't lower costs.
Read More
What We're Reading: Should the FDA Change How Drugs Are Approved in the US?
June 30th 2016What we're reading, June 30, 2016: one doctor makes the case for the FDA moving away from a simple approval/no approval system; Massachusetts and Gilead come to an agreement over hepatitis C drug rebates; and Georgia considers Medicaid expansion.
Read More
Segment 8: Creating Quality Benchmarks for Oncologists
June 29th 2016Measuring quality is important in determining whether patients are getting the appropriate care they need, and according to Linda Bosserman, MD, assistant clinical professor and staff physician, City of Hope, quality measures should cater to the patient’s unique needs.
Read More
Segment 7: The Importance of Interoperable EHRs in Care Quality
June 29th 2016From a health plan perspective, the key to effectively using electronic health records, or EHRs, is to leverage the infrastructure in a manner that takes the burden away from the physician and his or her practice, said Jennifer Malin, MD, staff vice president, Clinical Strategy, Anthem.
Read More
Segment 6: Interoperability Can Add Value to Care Coordination
June 29th 2016Data interoperability remains a challenge among practicing physicians and health plans, mainly because each system operates on its own standards and vocabulary, explained Jason C. Goldwater, MA, MPA, senior director, National Quality Forum.
Read More
Segment 5: Developing Appropriate PRO-PMs
June 29th 2016Patient-reported outcome measures help providers and health plans better understand what the patient wants and needs; however, there are still many challenges standing in the way of reaching its full potential, said Jason C. Goldwater, MA, MPA, senior director, National Quality Forum.
Read More
Segment 3: Choosing Between Process Measures and Outcomes Measures
June 29th 2016While the science of quality measurements is still in its infancy, Jennifer Malin, MD, staff vice president, Clinical Strategy, Anthem, said these metrics have allowed her and her team to open the door of communication among providers on how important quality truly is.
Read More